SCHEMBL29636809

SCHEMBL29636809

COc1ccc(-c2cc(Cl)c3cc(OC)ccc3n2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.65
PLA2G2A P14555 5/20 0.60
AURKA O14965 1/20 0.60
AURKB Q96GD4 1/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
ESRRB O95718 1/20 0.56
ESR1 P03372 1/20 0.56
ESRRA P11474 1/20 0.56
ESR2 Q92731 1/20 0.56
ALDH1A1 P00352 2/20 0.56
MAPT P10636 2/20 0.56
ACACA Q13085 1/20 0.56
LMNA P02545 1/20 0.56
HPGD P15428 1/20 0.56
HTT P42858 1/20 0.56
ACP1 P24666 3/20 0.51
DHODH Q02127 1/20 0.51
TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4496204 1.00 KDM4E (0.65) KDM4EPLA2G2AAURKAAURKBSMN1; SMN2
SCHEMBL6534209 0.92 KDM4E (0.71) KDM4EPLA2G2AAURKAAURKBSMN1; SMN2
SCHEMBL1289553 0.88 ACP1 (0.56) KDM4EPLA2G2AAURKAAURKBSMN1; SMN2
SCHEMBL6534170 0.88 KDM4E (0.58) KDM4EPLA2G2AAURKAAURKBSMN1; SMN2
SCHEMBL4909833 0.87 KDM4E (0.59) KDM4EPLA2G2AAURKAAURKBSMN1; SMN2
SCHEMBL29636789 0.86 MAPT (0.71) KDM4EAURKAAURKBSMN1; SMN2ALDH1A1
SCHEMBL6534318 0.86 MAPT (0.71) KDM4EAURKAAURKBSMN1; SMN2ALDH1A1
SCHEMBL23015316 0.85 KDM4E (0.61) KDM4EPLA2G2AAURKAAURKBSMN1; SMN2
SCHEMBL29636817 0.85 KDM4E (0.61) KDM4EPLA2G2AAURKAAURKBSMN1; SMN2
SCHEMBL4475462 0.84 KDM4E (0.53) KDM4EPLA2G2AAURKAAURKBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4017492-A1 MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS Biohaven Therapeutics Ltd. (US) 2022-06-29 EP disclosed
CN-114667145-A Molecules that bind to TDP-43 for the treatment of amyotrophic lateral sclerosis and related disorders 拜尔哈文制药股份有限公司 2022-06-24 CN disclosed